APIs (active pharmaceutical ingredients)

2021 year-end wrapup

Industry insights: obstacles, positives, and looking ahead

16-Dec-2021 By Jenni Spinner

Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.

CPHI WORLDWIDE

Carrier solution addresses challenging liquid APIs: W.R. Grace

03-Nov-2021 By Jenni Spinner

The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.

From the show floor: Exhibitors at CPhI Worldwide 2021

03-Nov-2021 By Rachel Arthur

CPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.

Tech Innovations: October 2021

21-Oct-2021 By Jenni Spinner

This month’s list of partnerships, manufacturing facilities, new technologies and other items includes AstraZeneca, Charles River, Veeva, and other firms.

WashU report highlights vulnerabilities in US pharma supply chain

24-Aug-2021 By Jenni Spinner

According to the study, the country’s overreliance on pharmaceutical ingredients manufactured in overseas factories threatens national security and health.

3D tablet printing needs the right excipient: DFE Pharma

18-Aug-2021 By Jenni Spinner

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

SPI launches UltraBurst excipient designed for ODT formulation

18-Aug-2021 By Jenni Spinner

The pjarmaceutical excipient, intended for use in the formulation of flash orally dissolving tablets, is designed to disintegrate in less than 10 seconds.

Secure pharma supply chain requires connections, information

18-Aug-2021 By Jenni Spinner

A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patients—and how one solution can close the gap.

People on the Move: July 2021

08-Jul-2021 By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

CPHI NORTH AMERICA

Look for ‘supercharged’ collaboration in coming months: CPhI

28-Jun-2021 By Jenni Spinner

As the industry begins coming out of the COVID-19 pandemic, experts advise keeping an eye on growth and partnership opportunities in the US pharma market.

DCAT Week 2021 to take on industry education, innovation

24-Jun-2021 By Jenni Spinner

The annual event (scheduled July 12-16 online) will feature educational sessions, presentations, and networking opportunities for drug manufacturing pros.

Hot-melt extrusion can improve bioavailability: Avomeen

14-Jun-2021 By Jenni Spinner

With bioavailability challenges a frequent frustration for drug developers, one research outfit suggests a technique that could reduce the headaches.

Update on FDA COVID-19 activity, advice, and action

08-Jun-2021 By Jenni Spinner

The US agency’s latest actions and advice against the virus include information on test recalls, , approval and reauthorization of treatments, and more.

Tech Innovations: May 2021

19-May-2021 By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

Ampac announces $25m expansion of pharma manufacturing facility

19-May-2021 By Jenni Spinner

The company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

14-May-2021 By Jane Byrne

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative...

Interline Therapeutics lands $92m to map, correct dysfunctional proteins

13-May-2021 By Jenni Spinner

The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs.

Could synthetic biology solutions fix supply chain challenges?

11-May-2021 By Jenni Spinner

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

Indian trial of potential COVID-19 therapy yields positive results

10-May-2021 By Jenni Spinner

Organicell has announced the initial results from its India-based trial of the COVID-19 treatment Zofin look promising, plans to expand to more patients.

Lonza expands solid-form services at Oregon facility

01-Mar-2021 By Jenni Spinner

The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Sanofi unveils EUROAPI as name of new API company

14-Jan-2021 By Jenni Spinner

The global pharmaceutical firm expects big things from its newly formed active pharmaceutical ingredients company, to be led by new CEO Karl Rotthier.

Supply chain woes can lead to billion-dollar problems: Cloudleaf

23-Dec-2020 By Jenni Spinner

A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.

Stay on top of your pharma supply chain in 2021: PCI

17-Dec-2020 By Jenni Spinner

According to an executive from the drug development services company, pharma professionals should pay close attention to supply chain continuity and safety in the coming year.

Data explosion leads to opportunities, obstacles: ACD/Labs

16-Dec-2020 By Jenni Spinner

A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.

Almac secures grant to scale COVID-19 drug production

25-Nov-2020 By Jenni Spinner

The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.

People on the Move: November 2020

05-Nov-2020 By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

WuXi STA: increasing demand fueling ‘robust’ HPAPI market

29-Oct-2020 By Jenni Spinner

A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and what’s ahead for their operation.

CPhI Festival of Pharma

CPhI, Pharmapack Europe to return in 2021

08-Oct-2020 By Jenni Spinner

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

People on the Move: October 2020

07-Oct-2020 By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

CPhI Festival of Pharma

CPhI Pharma Index survey reveals minds of CEOs

01-Oct-2020 By Jenni Spinner

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.